Btg Pactual Global Asset Management LTD Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Btg Pactual Global Asset Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$59.04 - $77.95 $206,640 - $272,825	-3,500 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$29.01 - $74.23 $116,040 - $296,920	-4,000 Reduced 53.33%	3,500 $256,000
Q1 2020 May 12, 2020	BUY	$27.51 - $57.29 $206,325 - $429,675	7,500 New	7,500 $255,000
Q4 2019 Feb 13, 2020	SELL	$40.86 - $57.65 $649,919 - $916,980	-15,906 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$37.38 - $49.47 $220,766 - $292,169	5,906 Added 59.06%	15,906 $664,000
Q2 2019 Aug 13, 2019	BUY	$39.79 - $67.01 $397,900 - $670,100	10,000 New	10,000 $438,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Btg Pactual Global Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Btg Pactual Global Asset Management LTD with notifications on news.